RVMD
Revolution Medicines Inc
NASDAQ: RVMD · HEALTHCARE · BIOTECHNOLOGY
$140.55
-2.96% today
Updated 2026-04-29
Market cap
$29.88B
P/E ratio
—
P/S ratio
9,035.10x
EPS (TTM)
$-5.95
Dividend yield
—
52W range
$34 – $156
Volume
3.1M
Revolution Medicines Inc (RVMD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-58.10%
ROA
-30.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $0.00 | $-31.13M | — | — | — |
| 2018 | $20.16M | $-41.79M | 100.00% | -200.00% | -207.24% |
| 2019 | $50.04M | $-47.66M | 100.00% | -108.15% | -95.25% |
| 2020 | $42.98M | $-108.16M | 100.00% | -257.54% | -251.63% |
| 2021 | $29.39M | $-187.09M | 100.00% | -639.70% | -636.58% |
| 2022 | $35.38M | $-248.71M | 100.00% | -730.01% | -702.95% |
| 2023 | $11.58M | $-436.37M | 100.00% | -4,207.12% | -3,768.28% |
| 2024 | $0.00 | $-600.09M | — | — | — |
| 2025 | $0.00 | $-1.13B | — | — | — |